CIK: 1265801 - Address: 1200 Avenue of the Americas, Suite 200, New York, NY 10036
21 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret111346102356420
P%wins92837567737077
S%ret313-52-4-8-37-17-11
S%wins1003367671006772

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/16/18 19:16
11/15/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPhillips Barclay ANCOSVP,CFOM.d9719.46050D
11/16/18 19:16
11/15/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsPhillips Barclay ANCOSVP,CFOS.d-20039.920-5-1000D
8/1/17 17:26
7/31/17
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP20.890002639D
5/11/17 10:45
5/11/17
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP210.838042521537D-90-82-44-37-35111212
2/2/17 16:10
1/31/17
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP21.12821612D-83-72-82-14-7-4-4-24215-38
8/2/16 18:17
7/31/16
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP24.29310410D69-3946388-5-1-164-3-78-80
2/1/16 17:34
1/31/16
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP24.38330410D-10-34-57-30-41-27-17-9-7-4-7444-73
8/21/15 17:08
8/19/15
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOS.m-37413.0633-29-769D315174303932-11-13-12-4-18-36-58-42
8/4/15 16:46
7/31/15
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP22.28331238D3521845751220122-5-10-41-58-38
2/3/15 17:05
1/31/15
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP192.283382937D3314281373020513718760-36
10/6/14 10:17
10/3/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP214.111252129D72270-13-9-9-5-12734439573
8/4/14 15:12
7/31/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP202.281495924D9559-22-1-15-5-6-532143281184
3/25/14 14:09
3/25/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP.a214.253355115D2159132-12-29-35-24-208101184124
3/25/14 12:07
3/25/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP214.253355115D2159132-12-29-35-24-208101184124
2/4/14 09:22
1/31/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP232.293210New10D251194997113-4-17-721020-18-1741
7/5/13 13:03
6/12/13
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP,CFOP.a00.00300D1651193152116151191338122113
7/3/13 10:40
6/12/13
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDDP951.9035033200D115319-6151812144161941128123
11/12/09 16:01
11/9/09
MITIMicromet, Inc.DEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP , CFM.d892.542351M27145754617259-27-122-56
11/12/09 16:01
11/9/09
MITIMicromet, Inc.DEHealthBioPrdBiological Products, (No DiagPhillips Barclay AMDOSVP , CFS.d-2146.102-35-961M27145754617259-27-122-56
6/16/08 16:04
6/13/08
ACORAcorda Therapeutics IncHealthBioPrdBiological Products, (No DiagPhillips Barclay ANYDS-7,12030.3033-235-27641I827676665424730-138-11-47-14
11/6/03 18:01
11/4/03
CNVXCancervax CorpDEHealthBioPrdBiological Products, (No DiagPhillips Barclay ACADP612.000187M

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact